Aug 13 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* ITERUM THERAPEUTICS PLC - QTRLY EARNINGS PER SHARE $0.04
* ITERUM THERAPEUTICS PLC - QTRLY ADJUSTED LOSS PER SHARE
$0.04
* ITERUM THERAPEUTICS PLC - AS OF JUNE 30, 2021, HAD CASH,
CASH
EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $91.4 MILLION
* ITERUM THERAPEUTICS PLC - EXPECTS CURRENT CASH, CASH
EQUIVALENTS, SHORT-TERM INVESTMENTS WILL BE SUFFICIENT TO FUND
ITS OPERATIONS INTO H2 2023
Source text for Eikon: ID:nGNX8LkW0q
Further company coverage: ITRM.O
((Reuters.Briefs@thomsonreuters.com;))